

( (S (NP-SBJ EG&G Inc.)
     (VP said
         (SBAR 0
               (S (NP-SBJ it)
                  (VP acquired
                      (NP (NP Laboratorium Prof. Dr. Berthold)
                          ,
                          (NP (NP a German maker)
                              (PP of
                                  (NP scientific instruments))))))))
     .))
( (S (NP-SBJ-1 Terms)
     (VP were n't
         (VP disclosed
	     (NP *-1)))
     .))
( (S (NP-SBJ (NP The
		 (NAC-LOC Wellesley
			  ,
			  Mass.
			  ,)
		 maker)
             (PP of
                 (NP (NP scientific instruments)
                     and
                     (NP electronic parts))))
     (VP said
         (SBAR 0
               (S (NP-SBJ Berthold)
                  (VP (VP expects
                          (NP (NP 1989 sales)
                              (PP of
                                  (NP (NP (QP more than 100 million)
                                          Deutsche marks)
                                      (PRN -LRB-
					   (NP (QP $ 54.5 million) *U*)
					   -RRB-)))))
                      and
                      (VP employs
                          (NP (QP about 400) people))))))
     .))
( (S (NP-SBJ-1 Berthold)
     (VP (VP is
	     (VP based
		 (NP *-1)
		 (PP-LOC-CLR in
			     (NP (NP Wildbad)
				 ,
				 (NP West Germany)
				 ,))))
	 and
	 (VP (ADVP also)
	     has
	     (NP (NP operations)
		 (PP-LOC in
			 (NP Belgium)))))
     .))
( (S (NP-SBJ (NP John M. Kucharski)
             ,
             (NP (NP EG&G 's)
                 (NX (NX chairman) and (NX chief executive)))
             ,)
     (VP said
         (SBAR 0
               (S (NP-SBJ the acquisition)
                  ``
                  (VP will
                      (VP (VP extend
                              (NP (NP EG&G 's)
                                  core technologies))
                          ,
                          (VP strengthen
                              (NP (NP its position)
                                  (PP-LOC in
					  (NP the European Economic Community))))
                          and
                          (VP assure
                              (NP (NP a strength and presence)
                                  (PP-LOC in
					  (NP the Eastern European market)))))))))
     .
     ''))
( (S (NP-SBJ He)
     (VP said
         (SBAR 0
               (S (NP-SBJ it)
                  (ADVP especially)
                  (VP will
                      (VP strengthen
                          (NP (NP (NP the company 's)
				  efforts)
                              (PP-LOC (PP in
					  (NP (NP the
						  (ADJP rapidly growing)
						  field)
					      (PP of
						  (NP bio-analytical instrumentation))))
				      , and
				      (PP in
					  (NP applied nuclear physics)))))))))
     .))
( (S (ADVP Separately)
     ,
     (NP-SBJ EG&G)
     (VP said
         (SBAR 0
               (S (NP-SBJ it)
                  (VP sold
                      (NP (NP most)
			  (PP of
			      (NP its Mason Research Institute subsidiary)))
                      (PP-DTV to
			      (NP (NP Transgenic Sciences Inc.)
				  ,
				  (NP (NP a (ADJP closely held) biotechnology company)
				      (VP based
					  (NP *)
					  (PP-LOC-CLR in
						      (NP (NP Worcester)
							  ,
							  (NP Mass)))))))))))
     .))
( (S (S-TPC-1 (NP-SBJ (NP The sale)
		      ,
		      (PP for
			  (NP (NP (QP $ 7 million) *U*)
			      (PP in
				  (NP cash
				      and
				      securities))))
		      ,)
	      (VP will
		  (VP leave
		      (NP EG&G)
		      (PP-CLR with
			      (NP (NP a (ADJP 12 %) stake)
				  (PP in
				      (NP Transgenic)))))))
     ,
     (NP-SBJ executives)
     (VP said
	 (SBAR 0
	       (S *T*-1)))
     .))
( (S (NP-SBJ Mason)
     (VP is
         (NP-PRD (NP the largest toxicology lab)
		 (PP-LOC in
			 (NP New England)))
	 ,
	 (PP with
	     (NP (NP (NP annual revenue)
		     (PP of
			 (NP (QP $ 8 million) *U*)))
		 and
		 (NP 140 employees))))
     .))
( (S (NP-SBJ Mason)
     (VP serves
         (NP (NP commercial and government customers)
             ,
	     (PP including
		 (NP (NP the National Institutes)
		     (PP of
			 (NP Health))))))
     .))
( (SINV (S-TPC-1 (NP-SBJ The combined companies)
		 (VP will
		     (VP become
			 (ADJP-PRD profitable)
			 (PP-TMP by
				 (NP January 1990)))))
	,
	(VP said
	    (SBAR 0
		  (S *T*-1)))
	(NP-SBJ (NP James P. Sherblom)
		,
		(NP (NP Transgenic 's)
		    (NX (NX chairman) and (NX chief executive officer))))
	.))
